Company page

U.s. Stem Cell, Inc.

U.S. Stem Cell, Inc. (ticker: USRM) is a public company operating in the American market, focusing on stem cell research and therapies. The company has a market capitalization of approximately $64,150.70. U.S. Stem Cell aims to advance the field of regenerative medicine through its innovative approaches and products.